Consistent with the flow cytometry-based assay data (Figure 4), the microscopy-based TUNEL assays revealed that CD133 aptamer-mediated delivery of DOX resulted in approximately 180% more apoptosis in HCC tumorsphere-forming cells than those treated by free DOX. The gene discussed is PROM1; the disease is hepatocellular carcinoma.